96
Views
8
CrossRef citations to date
0
Altmetric
Review

Role of 5-HT2C receptor gene variants in antipsychotic-induced weight gain

, , &
Pages 83-93 | Published online: 18 Aug 2011
 

Abstract

Antipsychotic-induced weight gain is a serious side effect of antipsychotic medication that can lead to increased morbidity, mortality, and non-compliance in patients. Numerous single nucleotide polymorphisms have been studied for association with antipsychotic-induced weight gain in an attempt to find genetic predictors of this side effect. An ability to predict this side effect could lead to personalized treatment plans for predisposed individuals, which could significantly decrease the prevalence and severity of weight gain. Variations in the serotonin receptor 2c gene (HTR2C) have emerged as promising candidates for prediction of antipsychotic-induced weight gain. Specifically, the well-studied −759C/T promoter polymorphism has been associated with weight gain in diverse populations, although some studies have reported no association. This discrepancy is likely due to heterogeneity in study design with respect to ethnicity, treatment duration, and other variables. Notably, the association between HTR2C and antipsychotic-induced weight gain appears strongest in short-term studies on patients with limited or no previous antipsychotic treatment. Other, less extensively studied promoter polymorphisms (−697C/G, −997G/A, and −1165A/G) have also emerged as potential predictors of antipsychotic-induced weight gain. Conversely, the well-studied intronic polymorphism Cys23Ser does not appear to be associated. With further research on both HTR2C and other genetic and environmental predictors of antipsychotic-induced weight gain, a predictive test could one day be created to screen patients and provide preventative or alternative treatment for those who are predisposed to this serious side effect.

Acknowledgements

CIHR operating grant to DJM (Genetics of antipsychotics induced metabolic syndrome, MOP 89853); NARSAD Young Investigator Award to DJM, CIHR Michael Smith New Investigator Salary Prize for Research in Schizophrenia to DJM, OMHF New Investigator Fellowship to DJM.

Disclosure

The authors report no conflicts of interest in this work.